These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 33464021

  • 1. Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092.
    Owor M, Tierney C, Ziemba L, Browning R, Moye J, Graham B, Reding C, Costello D, Norman J, Wiesner L, Hughes E, Whalen ME, Purdue L, Mmbaga BT, Kamthunzi P, Kawalazira R, Nathoo K, Bradford S, Coletti A, Aweeka F, Musoke P.
    Pediatr Infect Dis J; 2021 May 01; 40(5):446-452. PubMed ID: 33464021
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessment of lamivudine, zidovudine, lopinavir, and ritonavir plasma levels in HIV-positive pregnant women: Drug monitoring application to improve patient safety.
    Hernández-Pineda J, Jung-Cook HH, Katende-Kyenda NL, Galindo-Sevilla N, Domínguez-Castro M, Romo-Yañéz J, Ramírez-Ramírez A, Irles C, Figueroa-Damián R.
    Medicine (Baltimore); 2020 May 29; 99(22):e20487. PubMed ID: 32481459
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
    Chokephaibulkit K, Cressey TR, Capparelli E, Sirisanthana V, Muresan P, Hongsiriwon S, Ngampiyaskul C, Limwongse C, Wittawatmongkol O, Aurpibul L, Kabat B, Toye M, Smith ME, Eksaengsri A, McIntosh K, Yogev R, IMPAACT P1069 Team.
    Antivir Ther; 2011 May 29; 16(8):1287-95. PubMed ID: 22155910
    [Abstract] [Full Text] [Related]

  • 5. Low Third-Trimester Serum Levels of Lamivudine/Zidovudine and Lopinavir/Ritonavir in an HIV-Infected Pregnant Woman with Gastric Bypass.
    Michalik DE, Jackson-Alvarez JT, Flores R, Tolentino-Baldridge C, Batra JS.
    J Int Assoc Provid AIDS Care; 2015 May 29; 14(2):116-9. PubMed ID: 25361558
    [Abstract] [Full Text] [Related]

  • 6. The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children.
    Musiime V, Fillekes Q, Kekitiinwa A, Kendall L, Keishanyu R, Namuddu R, Young N, Opilo W, Lallemant M, Walker AS, Burger D, Gibb DM.
    J Acquir Immune Defic Syndr; 2014 Jun 01; 66(2):148-54. PubMed ID: 24828266
    [Abstract] [Full Text] [Related]

  • 7. A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines.
    Pinto JA, Capparelli EV, Warshaw M, Zimmer B, Cressey TR, Spector SA, Qin M, Smith B, Siberry GK, Mirochnick M, IMPAACT P1083 Team.
    Pediatr Infect Dis J; 2018 Feb 01; 37(2):e29-e35. PubMed ID: 29088027
    [Abstract] [Full Text] [Related]

  • 8. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.
    Dahourou DL, Amorissani-Folquet M, Malateste K, Amani-Bosse C, Coulibaly M, Seguin-Devaux C, Toni T, Ouédraogo R, Blanche S, Yonaba C, Eboua F, Lepage P, Avit D, Ouédraogo S, Van de Perre P, N'Gbeche S, Kalmogho A, Salamon R, Meda N, Timité-Konan M, Leroy V, MONOD Study Group.
    BMC Med; 2017 Apr 24; 15(1):85. PubMed ID: 28434406
    [Abstract] [Full Text] [Related]

  • 9. Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy.
    Sripan P, Le Coeur S, Ingsrisawang L, Cressey TR, Bouazza N, Foissac F, Ngo-Giang-Huong N, Traisathit P, Srirompotong U, Ayudhaya OP, Puangsombat A, Jungpipun J, Jittayanun K, Tréluyer JM, Jourdain G, Lallemant M, Urien S.
    Antivir Ther; 2016 Apr 24; 21(5):435-40. PubMed ID: 26492107
    [Abstract] [Full Text] [Related]

  • 10. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection.
    Wang LH, Chittick GE, McDowell JA.
    Antimicrob Agents Chemother; 1999 Jul 24; 43(7):1708-15. PubMed ID: 10390227
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of steady-state pharmacokinetic interactions between ritonavir-boosted BILR 355, a non-nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjects.
    Huang F, Allen L, Huang DB, Moy F, Vinisko R, Nguyen T, Rowland L, MacGregor TR, Castles MA, Robinson P.
    J Clin Pharm Ther; 2012 Feb 24; 37(1):81-8. PubMed ID: 21128991
    [Abstract] [Full Text] [Related]

  • 12. Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men.
    Dumond JB, Reddy YS, Troiani L, Rodriguez JF, Bridges AS, Fiscus SA, Yuen GJ, Cohen MS, Kashuba AD.
    J Acquir Immune Defic Syndr; 2008 Jun 01; 48(2):156-62. PubMed ID: 18360288
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection.
    Fletcher CV, Yogev R, Nachman SA, Wiznia A, Pelton S, McIntosh K, Stanley K.
    Pharmacotherapy; 2004 Apr 01; 24(4):453-9. PubMed ID: 15098798
    [Abstract] [Full Text] [Related]

  • 14. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
    Cameron DW, Becker S, King MS, da Silva B, Klein C, Tokimoto D, Foit C, Calhoun D, Bernstein B, Hanna GJ.
    J Antimicrob Chemother; 2007 May 01; 59(5):957-63. PubMed ID: 17350990
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults.
    Crémieux AC, Katlama C, Gillotin C, Demarles D, Yuen GJ, Raffi F, AZl10002 Study Group.
    Pharmacotherapy; 2001 Apr 01; 21(4):424-30. PubMed ID: 11310515
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous determination of lamivudine, lopinavir, ritonavir, and zidovudine concentration in plasma of HIV-infected patients by HPLC-MS/MS.
    Notari S, Sergi M, Montesano C, Ivanovic J, Narciso P, Pucillo LP, Ascenzi P.
    IUBMB Life; 2012 May 01; 64(5):443-9. PubMed ID: 22473795
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study.
    Bekker A, Rabie H, Salvadori N, du Toit S, Than-In-At K, Groenewald M, Andrieux-Meyer I, Kumar M, Cressey R, Nielsen J, Capparelli E, Lallemant M, Cotton MF, Cressey TR, PETITE Study Team.
    J Acquir Immune Defic Syndr; 2022 Mar 01; 89(3):324-331. PubMed ID: 34855626
    [Abstract] [Full Text] [Related]

  • 18. Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial.
    Bekker A, Salvadori N, Rabie H, du Toit S, Than-In-At K, Groenewald M, Cressey R, Nielsen J, Capparelli EV, Lallemant M, Cotton MF, Cressey TR, PETITE-ABC/3TC-LPVr Study Team.
    Lancet HIV; 2024 Feb 01; 11(2):e86-e95. PubMed ID: 38296364
    [Abstract] [Full Text] [Related]

  • 19. Long-Acting Profile of 4 Drugs in 1 Anti-HIV Nanosuspension in Nonhuman Primates for 5 Weeks After a Single Subcutaneous Injection.
    McConnachie LA, Kinman LM, Koehn J, Kraft JC, Lane S, Lee W, Collier AC, Ho RJY.
    J Pharm Sci; 2018 Jul 01; 107(7):1787-1790. PubMed ID: 29548975
    [Abstract] [Full Text] [Related]

  • 20. Beneficial pharmacokinetic interaction between atazanavir and lopinavir/ritonavir.
    Pham PA, Flexner C, Parsons T, Vasist L, Fuchs E, Carson K, Agarwala S, Barditch-Crovo P.
    J Acquir Immune Defic Syndr; 2007 Jun 01; 45(2):201-5. PubMed ID: 17414932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.